Cramer’s lightning round: I like Truist

Cramer’s lightning round: I like Truist


PPG Industries Inc: “I think PPG is down too much. I think it’s okay, but … This is a company that has been really hurt by raw costs. That’s going to end eventually. I think if you can handle disappointment at this point, I would buy the stock.”

AppFolio Inc: “You’ve got a software portfolio that is meant for housing. And I think it’s much needed, and it reminds me very much of Anaplan, which got a bid today from Thoma Bravo.”

Berkshire Hathaway Inc Class B: ” I think [having it as more than a third of a portfolio is] a lot for any one particular company, but I do love the company so much. Let’s cut it to 20% [of a portfolio], so that we can sleep better at night.”

Star Bulk Carriers Corp: “I think the dividend’s too high, but for what’s going on right now in Ukraine, I think it’s actually going to be good for the next year.”

Vaalco Energy Inc: “This is, yes. It will work. It will work because [the price of] oil is so high, even though I don’t like their business model.”

Truist Financial Corp: “I like Truist. … They’re in the right place where wealth is, they’re a very smart-run bank, I think it’s a good place to be.”



Source

FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More
Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war
Business

Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war

Toyota Motor Corp. vehicles bound for shipment at the Port of Nagoya in Tokai, Aichi Prefecture, Japan, on Tuesday, April 29, 2025. Toru Hanai | Bloomberg | Getty Images DETROIT — Toyota Motor, Hyundai Motor and Chinese automakers such as Chery face the most potential impact of non-domestic automakers from the U.S.-Israel war with Iran, […]

Read More